Back to Search
Start Over
Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway.
- Source :
-
Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2016 Jan 04; Vol. 64, pp. 131-41. Date of Electronic Publication: 2015 Aug 09. - Publication Year :
- 2016
-
Abstract
- Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72 h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30-60 min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders.<br /> (Copyright © 2015. Published by Elsevier Inc.)
- Subjects :
- Animals
Antidepressive Agents pharmacology
Colitis pathology
Colitis physiopathology
Colitis psychology
Colon drug effects
Colon metabolism
Colon pathology
Crohn Disease drug therapy
Crohn Disease pathology
Depression drug therapy
Depression pathology
Disease Models, Animal
Enzyme Inhibitors pharmacology
Guanidines pharmacology
Hippocampus drug effects
Hippocampus metabolism
Hippocampus pathology
Male
Mice
Motor Activity drug effects
Motor Activity physiology
NG-Nitroarginine Methyl Ester pharmacology
Nitric Oxide Synthase Type II antagonists & inhibitors
Nitrites metabolism
Signal Transduction drug effects
Trinitrobenzenesulfonic Acid
Tumor Necrosis Factor-alpha metabolism
Crohn Disease physiopathology
Crohn Disease psychology
Depression physiopathology
Nitric Oxide metabolism
Nitric Oxide Synthase Type II metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1878-4216
- Volume :
- 64
- Database :
- MEDLINE
- Journal :
- Progress in neuro-psychopharmacology & biological psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 26268932
- Full Text :
- https://doi.org/10.1016/j.pnpbp.2015.08.004